Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland

Journal of Biological Chemistry

Volumn 289, Issue 32, 2014, Pages 22459-22469

  Paatero, Ilkka ^a,b   Seagroves, Tiffany N ^c   Vaparanta, Katri ^a   Han, Wen ^d   Jones, Frank E ^d   Johnson, Randall S ^e   Elenius, Klaus ^a,f  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d Tulane University   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

HYPOXIA-INDUCIBLE FACTOR 1; IN-VITRO; MAMMARY EPITHELIAL CELLS; MAMMARY GLAND; PROTEIN ACCUMULATION;

BIOLOGY;

EPIDERMAL GROWTH FACTOR RECEPTOR 4; ERBB4 PROTEIN, HUMAN; ERBB4 PROTEIN, MOUSE; HIF1A PROTEIN, HUMAN; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PEPTIDE FRAGMENT;

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DEFICIENCY; ENDOCYTOSIS; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; KNOCKOUT MOUSE; LACTATION; MAMMARY GLAND; METABOLISM; MOUSE; PREGNANCY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UDDER;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENDOCYTOSIS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LACTATION; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MICE; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PREGNANCY; RECEPTOR, ERBB-4; SIGNAL TRANSDUCTION;

EID: 84905858377     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.533497     Document Type: Article

References (46)

1. Pouysségur, J., Dayan, F., and Mazure, N. (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437-443
2. Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., and Semenza, G. L. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1. Genes Dev. 12, 149-162
3. Seagroves, T. N., Hadsell, D., McManaman, J., Palmer, C., Liao, D., Mc-Nulty, W., Welm, B., Wagner, K. U., Neville, M., and Johnson, R. S. (2003) HIF1 is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 130, 1713-1724
4. Holbro, T., and Hynes, N. (2004) ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol. 44, 195-217
5. Hynes, N. E., and MacDonald, G. (2009) ErbB receptors and signaling pathways in cancer. Curr. Opin. Cell Biol. 21, 177-184
6. Gullick, W. J. (2003) c-erbB-4/HER4: friend or foe? J. Pathol. 200, 279-281
7. Veikkolainen, V., Vaparanta, K., Halkilahti, K., Iljin, K., Sundvall, M., and Elenius, K. (2011) Function of ERBB4 is determined by alternative splicing. Cell Cycle 10, 2647-2657
8. Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., and Lemke, G. (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378, 390-394
9. Tidcombe, H., Jackson-Fisher, A., Mathers, K., Stern, D. F., Gassmann, M., and Golding, J. P. (2003) Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 100, 8281-8286
10. Veikkolainen, V., Naillat, F., Railo, A., Chi, L., Manninen, A., Hohenstein, P., Hastie, N., Vainio, S., and Elenius, K. (2012) ErbB4 modulates tubular cell polarity and lumen diameter during kidney development. J. Am. Soc. Nephrol. 23, 112-122
11. Jones, F. E., Welte, T., Fu, X. Y., and Stern, D. F. (1999) ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J. Cell Biol. 147, 77-88
12. Long, W., Wagner, K. U., Lloyd, K. C., Binart, N., Shillingford, J. M., Hennighausen, L., and Jones, F. E. (2003) Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130, 5257-5268
13. Junttila, T. T., Sundvall, M., Lundin, M., Lundin, J., Tanner, M., Härkönen, P., Joensuu, H., Isola, J., and Elenius, K. (2005) Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res. 65, 1384-1393
14. Määttä, J. A., Sundvall, M., Junttila, T. T., Peri, L., Laine, V. J., Isola, J., Egeblad, M., and Elenius, K. (2006) Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol. Biol. Cell 17, 67-79
15. Tvorogov, D., Sundvall, M., Kurppa, K., Hollmén, M., Repo, S., Johnson, M. S., and Elenius, K. (2009) Somatic mutations of ErbB4: selective lossof-function phenotype affecting signal transduction pathways in cancer. J. Biol. Chem. 284, 5582-5591
16. Pircher, T. J., Flores-Morales, A., Mui, A. L., Saltiel, A. R., Norstedt, G., Gustafsson, J. A., and Haldosén, L. A. (1997) Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5. Mol. Cell. Endocrinol. 133, 169-176
17. Litterst, C. M., Kliem, S., Marilley, D., and Pfitzner, E. (2003) NCoA-1/ SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the-helical region of the STAT5 transactivation domain. J. Biol. Chem. 278, 45340-45351
18. Kainulainen, V., Sundvall, M., Määttä, J. A., Santiestevan, E., Klagsbrun, M., and Elenius, K. (2000) A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis. J. Biol. Chem. 275, 8641-8649
19. Junttila, T. T., Laato, M., Vahlberg, T., Söderström, K. O., Visakorpi, T., Isola, J., and Elenius, K. (2003) Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin. Cancer Res. 9, 5346-5357
20. Paatero, I., Jokilammi, A., Heikkinen, P. T., Iljin, K., Kallioniemi, O. P., Jones, F. E., Jaakkola, P. M., and Elenius, K. (2012) Interaction with ErbB4 promotes hypoxia-inducible factor-1′ signaling. J. Biol. Chem. 287, 9659-9671
21. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., Tinevez, J. Y., White, D. J., Hartenstein, V., Eliceiri, K., Tomancak, P., and Cardona, A. (2012) Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682
22. Mazumdar, A., Wang, R. A., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., Vadlamudi, R. K., and Kumar, R. (2001) Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3, 30-37
23. Williams, C. C., Allison, J. G., Vidal, G. A., Burow, M. E., Beckman, B. S., Marrero, L., and Jones, F. E. (2004) The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167, 469-478
24. Beerli, R. R., Graus-Porta, D., Woods-Cook, K., Chen, X., Yarden, Y., and Hynes, N. E. (1995) Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and. Mol. Cell. Biol. 15, 6496-6505
25. Ni, C. Y., Murphy, M. P., Golde, T. E., and Carpenter, G. (2001)-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181
26. Hollmén, M., Liu, P., Kurppa, K., Wildiers, H., Reinvall, I., Vandorpe, T., Smeets, A., Deraedt, K., Vahlberg, T., Joensuu, H., Leahy, D. J., Schöffski, P., and Elenius, K. (2012) Proteolytic processing of ErbB4 in breast cancer. PLoS One 7, e39413
27. Goh, L. K., and Sorkin, A. (2013) Endocytosis of receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol. 5, a017459
28. Sundvall, M., Korhonen, A., Paatero, I., Gaudio, E., Melino, G., Croce, C. M., Aqeilan, R. I., and Elenius, K. (2008) Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms. Proc. Natl. Acad. Sci. U.S.A. 105, 4162-4167
29. Stenmark, H., Vitale, G., Ullrich, O., and Zerial, M. (1995) Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell 83, 423-432
30. Wang, Y., Roche, O., Yan, M. S., Finak, G., Evans, A. J., Metcalf, J. L., Hast, B. E., Hanna, S. C., Wondergem, B., Furge, K. A., Irwin, M. S., Kim, W. Y., Teh, B. T., Grinstein, S., Park, M., Marsden, P. A., and Ohh, M. (2009) Regulation of endocytosis via the oxygen-sensing pathway. Nat. Med. 15, 319-324
31. Muraoka-Cook, R. S., Sandahl, M. A., Strunk, K. E., Miraglia, L. C., Husted, C., Hunter, D. M., Elenius, K., Chodosh, L. A., and Earp, H. S., 3rd (2009) ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo. Mol. Cell. Biol. 29, 4935-4948
32. Muraoka-Cook, R. S., Sandahl, M., Husted, C., Hunter, D., Miraglia, L., Feng, S. M., Elenius, K., and Earp, H. S., 3rd (2006) The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol. Biol. Cell 17, 4118-4129
33. Sundvall, M., Peri, L., Määttä, J. A., Tvorogov, D., Paatero, I., Savisalo, M., Silvennoinen, O., Yarden, Y., and Elenius, K. (2007) Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains. Oncogene 26, 6905-6914
34. Sundvall, M., Korhonen, A., Vaparanta, K., Anckar, J., Halkilahti, K., Salah, Z., Aqeilan, R. I., Palvimo, J. J., Sistonen, L., and Elenius, K. (2012) Protein inhibitor of activated STAT3 (PIAS3) promotes sumoylation and nuclear sequestration of the intracellular domain of ErbB4. J. Biol. Chem. 287, 23216-23226
35. Das, P. M., Thor, A. D., Edgerton, S. M., Barry, S. K., Chen, D. F., and Jones, F. E. (2010) Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene 29, 5214-5219
36. Sundvall, M., Veikkolainen, V., Kurppa, K., Salah, Z., Tvorogov, D., van Zoelen, E. J., Aqeilan, R., and Elenius, K. (2010) Cell death or survival promoted by alternative isoforms of ErbB4. Mol. Biol. Cell 21, 4275-4286
37. Palmer, C. A., Neville, M. C., Anderson, S. M., and McManaman, J. L. (2006) Analysis of lactation defects in transgenic mice. J. Mammary Gland Biol. Neoplasia 11, 269-282
38. Schödel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C. W., Ratcliffe, P. J., and Mole, D. R. (2011) High-resolution genome-wide mapping of HIFbinding sites by ChIP-seq. Blood 117, e207-217
39. Hsu, T., Adereth, Y., Kose, N., and Dammai, V. (2006) Endocytic function of von Hippel-Lindau tumor suppressor protein regulates surface localization of fibroblast growth factor receptor 1 and cell motility. J. Biol. Chem. 281, 12069-12080
40. Avraham, R., and Yarden, Y. (2011) Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat. Rev. Mol. Cell Biol. 12, 104-117
41. Stiehl, D. P., Bordoli, M. R., Abreu-Rodríguez, I., Wollenick, K., Schraml, P., Gradin, K., Poellinger, L., Kristiansen, G., and Wenger, R. H. (2012) Non-canonical HIF-2 function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Oncogene 31, 2283-2297
42. Ciarloni, L., Mallepell, S., and Brisken, C. (2007) Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 104, 5455-5460
43. Luetteke, N. C., Qiu, T. H., Fenton, S. E., Troyer, K. L., Riedel, R. F., Chang, A., and Lee, D. C. (1999) Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126, 2739-2750
44. García-Rivello, H., Taranda, J., Said, M., Cabeza-Meckert, P., Vila-Petroff, M., Scaglione, J., Ghio, S., Chen, J., Lai, C., Laguens, R. P., Lloyd, K. C., and Hertig, C. M. (2005) Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle. Am. J. Physiol. Heart Circ. Physiol. 289, H1153-H1160
45. Compernolle, V., Brusselmans, K., Franco, D., Moorman, A., Dewerchin, M., Collen, D., and Carmeliet, P. (2003) Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1. Cardiovasc Res. 60, 569-579
46. Golding, J. P., Trainor, P., Krumlauf, R., and Gassmann, M. (2000) Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4. Nat. Cell Biol. 2, 103-109